Search Results - "Garon EB"

Author Correction: Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis.

Authors: Li S Noor ZS Zeng W et al.

Source: Nature communications [Nat Commun] 2026 Feb 05; Vol. 17 (1), pp. 1388. Date of Electronic Publication: 2026 Feb 05.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; In Process

Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers.

Authors: Andrea I Nañez Md Velez MA Mae Zakhour Md et al.

Source: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2025 Dec 01; Vol. 39 (10), pp. 456-462.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Internet ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study.

Authors: Skoulidis F Borghaei H Garon EB et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Nov 06; Vol. 17, pp. 17588359251386611. Date of Electronic Publication: 2025 Nov 06 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Characteristics of clinical trials associated with appeal and return on investment to participants: a review and framework.

Authors: Fernandez Turizo MJ Velez MA Glenn B et al.

Source: The oncologist [Oncologist] 2025 Oct 01; Vol. 30 (10).

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non-Small Cell Lung Cancer: The Phase 3 SKYSCRAPER-06 Randomized Clinical Trial.

Authors: Socinski MA Stahel R Lee DH et al.

Source: JAMA oncology [JAMA Oncol] 2026 Jun 01; Vol. 12 (6), pp. 619-627.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

Erratum: First-In-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2-Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non-Small-Cell Lung Cancer: TROPION-PanTumor01.

Authors: Shimizu T Sands J Yoh K et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jun; Vol. 44 (16), pp. 1560. Date of Electronic Publication: 2026 Apr 30.

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; In Process

Toward the simultaneous detection of multiple diseases with a highly cost-effective cell-free DNA methylome test.

Authors: Zeng W Liu CC Li S et al.

Source: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2026 Apr 14; Vol. 123 (15), pp. e2518347123. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article

Journal Info: Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Authors: Gray JE Neal JW Patel JD et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Apr 10. Date of Electronic Publication: 2026 Apr 10.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Stereotactic Body Radiation Therapy Utilization Trends for Stage I Non-Small Cell Lung Cancer.

Authors: Sakowitz S Tupper HI Benjamin LN et al.

Source: Chest [Chest] 2026 Apr; Vol. 169 (4), pp. 1142-1147. Date of Electronic Publication: 2025 Nov 12.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-3543 (Electronic) Linking ISSN: 00123692 NLM ISO Abbreviation: Chest Subsets: MEDLINE; In Process

Correction: cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution.

Authors: Li S Zeng W Ni X et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Mar 16; Vol. 32 (6), pp. 1181.

Publication Type: Published Erratum

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE; In Process

Macropinocytosis and Vascularization Determine Response to mTOR Inhibitors in Lung Squamous Cell Carcinoma.

Authors: Brady MR Matulionis N Christofk HR et al.

Source: Cancer research [Cancer Res] 2026 Mar 02; Vol. 86 (5), pp. 1166-1179.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE

First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS Less Than 50% and More Than or Equal to 50% Cohorts of the EVOKE-02 Study.

Authors: Reck M Patel JD Gray JE et al.

Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Mar; Vol. 21 (3), pp. 103509. Date of Electronic Publication: 2025 Oct 30.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

Adequacy of Immune Checkpoint Inhibitor-Associated Thyroid Function Monitoring After Therapy.

Authors: Velez MA Kang ES Thompson CA et al.

Source: JCO oncology practice [JCO Oncol Pract] 2026 Feb; Vol. 22 (2), pp. 306-313. Date of Electronic Publication: 2025 Jun 02.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Detecting HLA loss of heterozygosity within a standard diagnostic sequencing workflow for prognostic and therapeutic opportunities.

Authors: Lozac'hmeur A Danek T Yang Q et al.

Source: NPJ precision oncology [NPJ Precis Oncol] 2024 Aug 05; Vol. 8 (1), pp. 174. Date of Electronic Publication: 2024 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.

Authors: Garon EB Cho BC Luft A et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2024 May; Vol. 25 (3), pp. 266-273.e5. Date of Electronic Publication: 2024 Mar 15.

Publication Type: Journal Article; Clinical Trial, Phase III

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC.

Authors: Nishio M Seto T Reck M et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2025 Sep 26; Vol. 6 (12), pp. 100912. Date of Electronic Publication: 2025 Sep 26 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431].

Authors: Garassino MC Gadgeel S Novello S et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2025 Sep 02; Vol. 6 (10), pp. 100892. Date of Electronic Publication: 2025 Sep 02 (Print Publication: 2025).

Publication Type: Published Erratum

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

Identification of Targetable EGFR Mutations in Ovarian Cancer.

Authors: Gower A Win S Ganguly R et al.

Source: JCO precision oncology [JCO Precis Oncol] 2025 Sep; Vol. 9, pp. e2500390. Date of Electronic Publication: 2025 Sep 10.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Unbridled Enthusiasm for Neoadjuvant Chemoimmunotherapy followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.

Authors: Moghanaki D Cameron EA Garon EB

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Aug; Vol. 206, pp. 108628. Date of Electronic Publication: 2025 Jun 20.

Publication Type: Editorial

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE; In Process

Brief Report: The Genomic Landscape of Small Cell Lung Cancer in Never-Smoking Patients.

Authors: Oh MS Garon EB Lisberg AE et al.

Source: Clinical lung cancer [Clin Lung Cancer] 2025 Jul; Vol. 26 (5), pp. 434-439.e3. Date of Electronic Publication: 2025 Mar 31.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE